Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multicentre, Prospective, Single-Arm Study to Assess the Effect on Voluntary Movements of AbobotulinumtoxinA 1500 U Administered in Both Upper and Lower Limbs in Conjunction With a Guided Self-Rehabilitation Contract in Adult Subjects With Spastic Hemiparesis

NCT02969356 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02969356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02969356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multicentre, Prospective, Single-Arm Study to Assess the Effect on Voluntary Movements of AbobotulinumtoxinA 1500 U Administered in Both Upper and Lower Limbs in Conjunction With a Guided Self-Rehabilitation Contract in Adult Subjects With Spastic Hemiparesis
Lead sponsor
Ipsen
Phase
Phase 4
Overall status
Completed
Start date
December 18, 2016
Completion date
July 31, 2018
Enrollment
157 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

spastic hemiparesis